ArticleNeurocritical care2025
Neuroworsening in Traumatic Brain Injury: A Scoping Review of Definition, Prevalence, and Outcome.
Article in Neurocritical care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Neuroworsening in traumatic brain injury: A consensus of the Latin American Brain Injury Consortium (LABIC) and the Latin American Federation of Neurosurgical Societies (FLANC) expert group.Neurosurgical review · 2026Article
- Early Neurological Deterioration Prediction Model May Focus on Moderate and Severe Traumatic Brain Injury Populations.Neurocritical care · 2026Article
- Early mobilization in neurocritical care as a threshold-regulated intervention: a narrative review of mechanistic integration and implications for neurological recovery and physiological stability.Frontiers in neurology · 2026Review
- Development and validation of a risk stratification tool for 28-day mortality based on D-dimer to platelet ratio in moderate-to -severe traumatic brain injury: a retrospective cohort study.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeuroworsening (NW) refers to a state of deterioration of neurological status that occurs as a consequence of the progression of primary lesions or due to intracranial or systemic complications. NW has been associated with worse functional outcomes, and therefore its avoidance may improve prognosis. The objective of this scoping review was to analyze the definitions, prevalence, predisposing factors, and impact on the outcome of NW during all spectra of traumatic brain injury (TBI).
methodsWe performed a scoping review following Joanna Briggs Institute guidelines.
resultsA total of 92 studies were identified after the systematic review of the literature using four databases. After applying Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, 19 studies were included in the final analysis. Criteria used to define NW were not specified in ten studies, two studies used clinical criteria, two used radiological criteria, and five used a combination of clinical and radiological criteria. The mean prevalence of NW of the total population was 17%; whereas the mean prevalence was 28.2% for severe TBI, 23.4% for moderate TBI, and 6.42% for mild TBI. The predictors of NW were multiple, with a predominance of neuroimaging findings.
conclusionsNW is common after TBI, occurring in one in every five patients, and it is associated with high mortality and worse functional outcomes. The criteria to define NW has varied across studies; most used definitions based on clinical and neuroimaging criteria, but some included neuromonitoring parameters. Thus, lack of uniformity in the definition of NW remains a major limitation for the study of this major complication. A consensus to standardize the definition of NW and large-scale studies to determine its prevalence and risk factors are urgently needed.
Indexed as
Identifiers
40214891What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.